7/21/2020 7:10:58 AM
RedHill Biopharma Seeks SEC Review Of Suspicious Trading Activity
7/16/2020 8:20:16 AM
RedHill Receives Approval For Phase 2/3 Study In Russia On Opaganib In Severe COVID-19 Patients
4/27/2020 7:08:34 AM
RedHill Provides Addl Update On Compassionate Use Program With Opaganib
4/20/2020 9:11:47 AM
RedHill Enters Agreement With NIAID To Evaluate RHB-107 For COVID-19
4/17/2020 10:06:26 AM
RedHill Biopharma Updates On COVID-19 Compassionate Use With Opaganib In Israel; All Five Patients Shown Improved CRP
4/6/2020 6:10:31 AM
RedHill Biopharma: First Patient With COVID-19 Diagnosis Dosed With Opaganib
4/2/2020 2:10:09 AM
AstraZeneca Completes Divestment Of Movantik To RedHill Biopharma
3/11/2020 7:18:51 AM
RedHill Biopharma Provides Update On Clinical Development Programs For Opaganib
3/4/2020 7:13:05 AM
RedHill Biopharma FY Net Revenues $6.3 Mln Vs $8.4 Mln Last Year
1/2/2020 9:12:55 AM
RedHill Biopharma Regains Rights To Proprietary Bowel Preparation RHB-106
12/17/2019 8:25:04 AM
RedHill Biopharma Begins U.S. Promotion Of Aemcolo For Travelers' Diarrhea